Trial Profile
Efficacy and safety of everolimus as long-term treatment in Japanese patients with advanced pancreatic neuroendocrine tumours.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 Aug 2015
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Neuroendocrine tumours; Pancreatic cancer
- Focus Therapeutic Use
- 12 Aug 2015 New trial record